Adili Tsaba
Technik-/Wissenschafts-/F&E-Leiter bei VESSL Therapeutics Ltd.
Aktive Positionen von Adili Tsaba
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - |
| General Counsel | 01.01.2001 | - |
Karriereverlauf von Adili Tsaba
Ausbildung von Adili Tsaba
| Technion-Israel Institute of Technology | Undergraduate Degree |
Statistik
International
| Israel | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Börse
- Insiders
- Adili Tsaba
- Erfahrung
